COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States
Background: Scientific evidence is lacking regarding the risk of patients with chronic liver disease (CLD) for COVID-19, and how these risks are affected by age, gender and race. Methods: We performed a case-control study of electronic health records of 62.2 million patients (age >18 years) in th...
Main Authors: | QuanQiu Wang, Pamela B. Davis, Rong Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | EClinicalMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537020304326 |
Similar Items
-
Comorbidities and Outcome of Alcoholic and Non-Alcoholic Liver Cirrhosis in Taiwan: A Population-Based Study
by: Tzu-Wei Yang, et al.
Published: (2020-04-01) -
Alcoholic Liver Cirrhosis in Young Female: Diagnostic and Therapeutic Challenge
by: Syifa Mustika, et al.
Published: (2017-12-01) -
Molecular Basis and Current Treatment for Alcoholic Liver Disease
by: Juan Armendariz-Borunda, et al.
Published: (2010-04-01) -
Proteome analysis of liver nonparenchymal cells from rats with alcoholic liver fibrosis
by: ZHANG Lijun
Published: (2014-10-01) -
Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis
by: Chisato Saeki, et al.
Published: (2021-07-01)